An Amazon company logo marks the facade of a building in Schoenefeld near Berlin, March 18, 2022. (AP Photo/Michael Sohn, File)
Amazon is taking another shot at becoming a regular health care source for customers with the launch of a service centered on virtual care.
The e-commerce giant says its Prime customers can now get quick access to a health care provider through a program that costs $9 a month or $99 annually.
The company has made a number of attempts to incorporate healthcare into its platform and has started building momentum after some initial setbacks.
The company announced in August that it was adding video telemedicine visits in all 50 states to a virtual clinic it launched last year.
Yet Amazon shut down a virtual health care service last year that it spent years developing, and it was part of a high-profile but failed push to address health care costs in a partnership with two other major companies, Berkshire Hathaway and JPMorgan.
Through the new service, patients will be able to connect virtually around the clock with care providers through its Prime One Medical membership program. The service includes video chats and an option to make in-person visits if there are One Medical locations near by.
The company said Wednesday that its membership fee covers the cost for the virtual visits. But customers would have to pay for any visits they make to the company’s One Medical primary care offices. They can use insurance for that.
Virtual care grew popular during the COVID-19 pandemic, and many health care providers have since expanded their telemedicine offerings. It has remained popular as a convenient way to check in with a doctor or deal with relatively minor health issues like pink eye.
While virtual visits can improve access to help, some doctors worry that they also lead to care fragmentation and can make it harder to track a patient’s overall health. That could happen if a patient has a regular doctor who doesn’t learn about the virtual visit from another provider.
Updated November 9, 2023 at 4:46 p.m. ET to add missing word in the seventh paragraph and correct "last summer" to "last year" in sixth paragraph.
The CEO at Activision Blizzard Bobby Kotick apologized to employees after the company had been rocked by the public airing of sexual harassment claims that went unchecked. Kotick also asked that his compensation of more than $150 million be slashed to just over $62,000.
Cheddar's Ken Buffa took the Pixel 6 Pro for a test drive, highlighting some of the new features. The latest Google smartphone comes with an upgraded camera visor that holds three cameras in place as well as Gorilla Glass Victus covering the front and back protecting against drops and scratches. The device also contains Google's first homemade processor chip called Tensor and retails for about $899.
Overstock CEO Jonathan Johnson joined Cheddar's "Opening Bell" to talk about the company's Q3 earnings beat. While supply chain issues have plagued businesses across industries, Johnson noted that the company largely avoided constraints by not pressuring suppliers to fill Overstock's own distribution centers, encouraging them to use their own. "We have a higher in-stock percentage today than we did a year ago. Not quite as high as we did pre-pandemic but better than it was last year at this time," he said.
Google notified a number of small and medium-sized customers that potential antitrust bills could have negative impacts on their own businesses. The warning appears to be an effort to drum up enough opposition to give pause to lawmakers before enacting any such legislation.
Anthony Bartolacci, VP of financials of data Sensor Tower, joined Cheddar to talk about Robinhood's massive earnings miss. He attributed part of it to the platform's exposure to cryptocurrency and its lackluster performance in Q3 following volatility. Bartolacci also noted some headwinds from a drop in engagement on the platform due to people returning to work and having less time to day trade contributing to the miss.
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.